NeuroAIDS in Africa

Journal of NeuroVirology

Volumn 16, Issue 3, 2010, Pages 189-202

  Robertson, Kevin ^a   Liner, Jeff ^a   Hakim, James ^b   Sankalé, Jean Louis ^c   Grant, Igor ^d   Letendre, Scott ^d   Clifford, David ^e   Diop, Amadou Gallo ^f   Jaye, Assan ^g   Kanmogne, Georgette ^h   Njamnshi, Alfred ⁱ   Langford, T Dianne ^j   Weyessa, Tufa Gemechu ^k   Wood, Charles ^l   Banda, Mwanza ^m   Hosseinipour, Mina ⁿ   Sacktor, Ned ^o   Nakasuja, Noeline ^p   Bangirana, Paul ^p   Paul, Robert ^q   Joska, John ^r   Wong, Joseph ^s   Boivin, Michael ^t   Holding, Penny ^u   Kammerer, Betsy ^v   Van Rie, Annelies ^w   Ive, Prudence ^x   Nath, Avindra ^y   Lawler, Kathy ^z   Adebamowo, Clement ^aa   Royal Iii, Walter ^ab   Joseph, Jeymohan ^ac   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c Globomics   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^g MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^j TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ADDIS ABABA UNIVERSITY   (Ethiopia)

^l UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^m UNIVERSITY TEACHING HOSPITAL   (Zambia)

ⁿ UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^o JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^p MAKERERE UNIVERSITY   (Uganda)

^q UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^r UNIVERSITY OF CAPE TOWN   (South Africa)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t MICHIGAN STATE UNIVERSITY   (United States)

^u CASE WESTERN RESERVE UNIVERSITY   (United States)

^v HARVARD MEDICAL SCHOOL   (United States)

^w UNIVERSITY OF NORTH CAROLINA   (United States)

^x HELEN JOSEPH HOSPITAL   (South Africa)

^y JOHNS HOPKINS UNIVERSITY   (United States)

^z UNIVERSITY OF PENNSYLVANIA   (United States)

^aa INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^ab UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^ac NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

more..

Author keywords

HIV; Neurodevelopment; Neurology; Neuropsychology; Subtypes

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; AUTOPSY; BOTSWANA; CAMEROON; CHILD CARE; CHILD DEVELOPMENT; CLADISTICS; DEPRESSION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; EARLY INTERVENTION; ETHIOPIA; GAMBIA; GOOD CLINICAL PRACTICE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KENYA; MALAWI; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MOLECULAR EPIDEMIOLOGY; NERVE CELL DIFFERENTIATION; NEUROLOGIC EXAMINATION; NIGERIA; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK ASSESSMENT; SENEGAL; SOUTH AFRICA; SUICIDAL IDEATION; UGANDA; ZAMBIA;

AFRICA; AIDS DEMENTIA COMPLEX; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE;

EID: 77953187846     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550284.2010.489597     Document Type: Review

References (25)

1. Abubakar A, Holding P, van Baar A, Newton CR, van de Vijver FJ (2008). Monitoring psychomotor development in a resource-limited setting: an evaluation of the Kilifi Developmental Inventory. Ann Trop Paediatr 28: 217-226.
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
3. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 13: 67-72.
4. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vezinet F (1997). Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.JVirol 71:8893-8898.
5. Diamond GW, Kaufman J, Belman AL, Cohen L, Cohen HJ, Rubinstein A (1987). Characterization of cognitive functioning in a subgroup of children with congenital HIV infection. Arch Clin Neuropsychol 2: 245-256.
6. Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986). Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78: 678-687.
7. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J NeuroVirol 13: 195-202.
8. Hemelaar J, Gouws E, Ghys PD, Osmanov S (2006). Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20: W13-W23.
9. Hoelscher M, Dowling WE, Sanders-Buell E, Carr JK, Harris ME, Thomschke A, Robb ML, Birx DL, McCutchan FE (2002). Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS 16: 2055-2064.
10. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, I ND, Essex ME, S MB (1999). Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68-73.
11. Laeyendecker O, Li X, Arroyo M, McCutchan F, Gray R, Wawer M, Serwadda D, Nalugoda F, Kigozi G, Quinn T, and Rakai Health Science Program (2006). 13th Conference on Retroviruses and Opportunistic Infections; February 5-February 8, 2006; Denver, CO
12. LANL (2010). The circulating recombinant forms (CRFs). In: HIV Sequence Database. Los Alamos, NM: Los Alamos National Laboratory.
13. Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, An SF (2004). Cerebral CD8+ lymphocyto-sis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 108: 17-23.
14. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364: 1236-1243.
15. Poveda E, de Mendoza C, Parkin N, Choe S, Garcia-Gasco P, Corral A, Soriano V (2008). Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. AIDS 22: 611-616.
16. Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (2002). Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci USA 99: 14410-14415.
17. Riedel DJ, Pardo CA, McArthur J, Nath A (2006). Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol 2: 557-565. (Pubitemid 44445811)
18. Shelburne SA, Montes M, Hamill RJ (2006). Immune recon-stitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 57: 167-170.
19. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR, Fenyo EM, Albert J (1998). Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241: 181-188.
20. Van Rie A, Dow A, Mupuala A, Stewart P (2009). Neuro-developmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 52: 636-642.
21. Van Rie A, Mupuala A, Dow A (2008). Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics 122: e123-e128.
22. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D (2006). Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 42: 843-852.
23. Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A (2006). Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67: 383-388. (Pubitemid 44214957)
24. WHO/UNAIDS (2008). Report on the Global AIDS Epidemic. Epub: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ 2008-Global-report.asp
25. Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM (2010). Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics 125: e250-e260.